Purchase Order 75N93024P01156

Award Date 9/17/24
Potential Completion Date 11/16/24
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a wholly-owned subsidiary of Macrogen, Inc. The contract ceiling value is $9,999.30 and it is for DNA sequencing services. The contract is not set aside for any specific business category. Psomagen Inc. is a leading provider of genomic and molecular biology services to federal agencies, including the National Institutes of Health (NIH), U.S. Department...
This federal contract award, valued at $4,380.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for a "Human & Herpes Virus mRNA Sequencing Project" in accordance with Psomagen's quote. The contract is a Firm Fixed Price purchase order with an ultimate completion date of August 28, 2014. Psomagen Inc. is not a small business, and the contract did not utilize a set-aside. Macrogen,...
This federal contract award, valued at $9,970.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for the provision of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research initiatives. Psomagen Inc. has established itself as a key provider of genomic services to various federal agencies, particularly within...
This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
This $17,154.00 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Psomagen Inc. for library preparation and sequencing services. Psomagen is a for-profit organization that manufactures goods and provides multiomics contract laboratory services, including whole genome, RNA, and epigenomic sequencing. The company has previously supported research at...

This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024.

Psomagen Inc. is a subsidiary of Macrogen, Inc. and has established itself as a key provider of advanced sequencing and omics services to various federal agencies, particularly in the health and agricultural sectors. The company has performed a range of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, in support of research on neurodegenerative diseases, cancer, infectious diseases, and agricultural genetics. This contract does not have a set-aside designation.

In addition to this direct contract award, Psomagen Inc. also holds two significant federal Indefinite Delivery Vehicle (IDV) contracts. The first is a $80,000 single-award IDV from the USDA Animal and Plant Health Inspection Service for Sanger sequencing services to identify intercepted insects and other pests. The second is a $500 million single-award IDV from the NIH National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative, which will enable precision medicine approaches for cardiovascular, lung, blood, and sleep disorders.

Generated 9/22/24, 12:49 AM